References
- Alberts AW, Chen J, Kuron G, et al. (1980). Mevinolin: A highly potent competitive inhibitor of hydroxymethyl-glutaryl-coenzyme, a reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 77:3957–61
- Ali SS, Panda BP, Javed S, Ali M. (2007). Optimization of nutrient parameters for lovastatin production by Monascus purpureus MTCC 369 under submerged fermentation using response surface methodology. Appl Microbiol Biotechnol 73:1054–8
- Barrios-González J, Miranda RU. (2010). Biotechnological production and applications of statins. Appl Microbiol Biotechnol 85:869–83
- Chance B. (1972). Principles of differential spectrophotometry with special reference to the dual wavelength method. Method Enzymol 24:322–36
- Cowles JC. (1965). Theory of dual-wavelength spectrophotometry for turbid samples. J Opt Soc Am 55:690–3
- Endo A. (1979). Monacolin K, a new hypocholesterolemic agent produced by a Monascus sp. J Antibiot 32:852–4
- Friedrich J, Bencina M, Cimerman A, et al. (1995). High performance liquid chromatographic analysis of mevinolin as mevinolinic acid in fermentation broths. J Chromatogr A 704:363–7
- Frishman WH, Zimetbaum P, Nadelmann J. (1989). Lovastatin and other HMG-CoA reductase inhibitors. J Clin Pharmacol 29:975–82
- Kysilka R, Kren V. (1993). Determination of lovastatin and mevinolinic acid in fermentation liquids. J Chromatogr A 630:415–17
- Li L, Sun J, Sun Y, He Z. (2008). LC–ESI–MS determination of lovastatin in human plasma. Chromatogr 67:621–5
- Li SW, Li M, Song HP, et al. (2011). Induction of a high-yield lovastatin mutant of Aspergillus terreus by 12C6+ heavy-ion beam irradiation and the influence of culture conditions on lovastatin production under submerged fermentation. Appl Biochem Biotechnol 165:913–25
- Mabrouk MM, Habeeb AA, Ei FHM. (1998). Spectrofluorimetric determination of the two antilipemic drugs lovastain and simvastatin in spiked human plasma and in dosage forms. Bull Fac Pharm 36:59–65
- Merrick LS, Anthony PS. (1989). The investigation of dual-wavelength spectroscopy for the analysis of dissolved drug in microcapsule suspensions. Int J Pharmaceut 50:39–43
- Miao XS, Metcalfe CD. (2003). Determination of cholesterol-lowering statin drugs in aqueous samples using liquid chromatography–electrospray ionization tandem mass spectrometry. J Chromatogr A 998:133–41
- Morris MJ, Gilbert JD, Hsieh YK. (1993). Determination of the HMG-CoA reductase inhibitors simvastatin, lovastatin, and pravastatin in plasma by gas chromatography/chemical ionization mass spectrometry. Biol Mass Spectrom 22:1–8
- Palego L, Giannaccini G, Saccomanni G, et al. (2010). Modified RP-LC of phenylthiocarbamyl amino acid adducts in plasma acetonitrile extracts using multiple internal standards and photo-diode UV detection. Chromatography 71:291–7
- Sorrentino F, Roy I, Keshavarz T. (2010). Impact of linoleic acid supplementation on lovastatin production in Aspergillus terreus cultures. Appl Microbiol Biotechnol 88:65–73
- Valera HR, Gomes J, Lakshmi S, et al. (2005). Lovastatin production by solid state fermentation using Aspergillus flavipes. Enzym Microb Tech 37:521–6
- Wang-Iverson D, Ivashkiv E, Jemal M, Cohen AI. (1989). Determination of lovastatin acid in serum by gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 3:132–4
- Ye LY, Patricia SF, Malcolm JM. (2000). Determination of lovastatin in human plasma using reverse-phrase high performance liquid chromatography with UV detection. Their Drug Monit 22:737–41
- Zhang Z, Yang Z. (2007). HPLC determination of lovastatin in rat tissue. Chromatography 66:487–91